In anticipation of its newly announced premiere date of Tuesday, December 6 at 10pm/9c, TELEMUNDO rolls out an exclusive digital prequel to the Super Series “El Chema” via Telemundo.com, VOD and the Telemundo Novelas app. With a script by writer Luis Zelkowicz, the “capítulo cero” (chapter zero) gives fans an exclusive look at El Chema’s backstory and what the character has been doing between the end of “El Señor de los Cielos” and the start of the new series. Starring Mauricio Ochmann, Mariana Seoane, Julio Bracho, Itatí Cantoral, Carmen Aub, Alexandra de la Mora, Arcelia Ramírez and Sergio Basáñez, the Super Series is directed by Danny Gavidia and Nicolás Di Blasi, and produced by Mariana Iskandarani and Patricia Benítez.
To view the multimedia release go to:
http://www.multivu.com/players/English/7980551-telemundo-el-chema-capitulo-cero/
Zero Gravity raised $665.00 for charity by jumping into the frozen waters of Crystal Lake on February 28th, 2009. Zero Gravity is a sportbike community in Minnesota. Check out www.teamzg.com for more info!
Ex CIA agent Jeff Aiken and DHS cybersecurity expert Daryl Haugen investigate random computer failures around the world and soon realize from clues in the viruses they discover that they are part of a larger attack. They race against time to learn who’s behind it and to stop it from happening. Learn about the book and the author here, http://www.zerodaythebook.com/ Cyber Thriller
A pill designed to zero in on abnormal genes that drive specific cancers has produced encouraging early results in children with an uncommon but aggressive type of lymphoma, as well as in children with a rare form of neuroblastoma.
A phase 1 clinical trial of the drug crizotinib achieved remissions, with minimal side effects, for 10 of the children participating in a clinical study carried out by the multicenter Children’s Oncology Group (COG). The results were “an exciting proof-of-principle” for the targeted treatment, said the study leader, Yaël P. Mossé, M.D., a pediatric oncologist at The Children’s Hospital of Philadelphia.
“We are entering a new era of cancer therapy, in which we use knowledge of basic biology to design very specific drugs that target cancer cells with potentially less side effects on healthy tissue,” said Mossé. “In addition, as we concentrate on targets in molecular pathways, we move away from an exclusive focus on one form of cancer to customizing treatments according to biological activity. Abnormal ALK activity occurs in subtypes of neuroblastoma and subtypes of lymphoma, so identifying ALK activity in individual patients may enable us to provide the most effective care.”
To view Multimedia News Release, go to http://www.multivu.com/mnr/50776-childrens-hospital-philadelphia-lymphoma-neuroblastoma-oncology-gene-trial
In partnership with Men’s Health Network (MHN), Prostate Health Education Network (PHEN), ZERO – the End of Prostate Cancer and Joe Torre, four-time world champion baseball Hall-of-Famer and prostate cancer survivor, Genomic Health, Inc. (Nasdaq: GHDX) today launched Your Prostate Your Decision to educate prostate cancer patients and their loved ones that every man is different and every cancer is unique, and a genomic test can clarify the aggressiveness of one’s disease prior to invasive treatment. This first-of-its-kind national effort aims to address concerning results of a large national survey that found low general awareness about prostate cancer aggressiveness and treatment options, underscoring the need for better understanding of active surveillance as a treatment plan.
“For a man with prostate cancer, a single decision can change his entire life,” said Mr. Torre, reflecting on his own experience with prostate cancer. “When I was diagnosed with prostate cancer, I faced a game-changing decision. While I chose surgery, a less aggressive approach called active surveillance might be the best choice.”
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7322251-your-prostate-your-decision-joe-torre-talks-about-prostate-cancer-genomic-testing-treatment-options-psa/
Get ready to take flight! The most highly anticipated thrill experience of 2012 is ready for launch. X Flight, an extreme, revolutionary wing coaster debuts today at Six Flags Great America. The Gurnee theme park’s newest coaster is one of the first-of-its-kind in the world.
X Flight is a ground-breaking wing coaster featuring state-of-the-art technology. X Flight launches riders on a flight that defies gravity, with no track above or below them. Riders sit in pairs, suspended on either side of the track with their feet dangling, as they begin their climb up a 12-story plunge launching them into speeds of 55mph through 3,000 feet of intense drops and five inversions, including a barrel roll and zero-g roll. One of the most adrenaline-pumping moments on the ride is an extreme fly-through where the coaster speeds straight toward a structure, before making a last-minute vertical flip through a keyhole cut-out.
To view Multimedia News Release, go to http://www.multivu.com/mnr/55453-six-flags-great-america-x-flight-cutting-edge-wing-coaster-takes-flight
Truvia®, the #1 natural zero calorie sweetener, announced the launch of a multimillion dollar integrated marketing campaign, “From Nature. For Sweetness.” The new creative campaign, kicked off on September 24th, will further drive consumer awareness, trial and adoption of Truvia® products in the U.S. Since opening the U.S. market for stevia-based sweeteners in 2008, the Truvia® brand has led the natural sweetener category and now holds a 61 percent market share.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58203-truvia-from-nature-for-sweetness-campaign-spotlights-stevia-sweetener
Today, Truvia™ natural sweetener, the great–tasting, zero-calorie sweetener made with rebiana, the best-tasting part of the stevia leaf, unveiled a new multi-million dollar print, television, digital and social media advertising campaign. As the leading natural zero-calorie sweetener and the third largest brand in the U.S. sugar substitute category, Truvia™ natural sweetener introduces the new “Sweetness Stories” campaign that builds on the success of the introduction that launched Truvia™ sweetener.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/truvia/46499/
The best hybrids give you the best of both worlds: some zero-emission motoring, as well as greater range for longer journeys
Subscribe for more videos from Auto Trader every Friday: http://bit.ly/1AqiIny
Welcome! Auto Trader is the UK’s biggest, best and most trusted car buying website, and our YouTube channel will help make finding your dream vehicle easier than ever.
Every week, we’ll present the latest new car reviews, covering everything from supercars to family estates. Our motoring experts have more than 75 years of testing experience between them, and their jargon-free verdicts cover real-world practicality, recommended specifications and reveal the real cost of ownership. Every video review is even complimented by a full written report on AutoTrader.co.uk.
But don’t just take our word for it; every month, we’ll ask some of Britain’s most passionate petrolheads to share their owner reviews. Factor in tutorials, used car guides, plus bonus motorcycle and van reviews and we have all your motoring needs covered.
Auto Trader: http://autotrader.co.uk?atcidi=yt-desc
Facebook: https://www.facebook.com/autotraderuk?
Twitter: https://twitter.com/AutoTrader_UK
Instagram: https://instagram.com/autotraderuk
Pinterest: https://www.youtube.com/user/autotraderuk
